Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the U.S. Food and Drug Administration ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

Dosing of the first participant commenced ahead of schedule and was rapidly followed by initial dosing in all trial participants.SLIM-1™ trial is ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. It's hard to watch the news or scroll through social media without encountering stories about weight loss drugs like semaglutide (the ...

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it's important to understand ...

Patients are overdosing on compounded semaglutide due to errors in measuring and self-administering the drug and due to clinicians miscalculating doses that may differ from US Food and Drug ...

WESTON, Fla., April 10, 2026 /PRNewswire/ - Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

Sun Pharma will launch the once-weekly diabetes treatment through Hypera Pharma as generic competition intensifies in ...